dr. richter discusses the administration of carfilzomib
Published 10 years ago • 201 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
1:54
dr. richter on findings of a study on symptom management in multiple myeloma
-
1:03
dr. richter on toxicities of treatments for multiple myeloma
-
1:00
dr. richter on the importance of optimizing available therapies in multiple myeloma
-
1:36
dr. richter on the utility of isatuximab in relapsed/refractory myeloma
-
10:31
carfilzomib use in multiple myeloma
-
1:07
dr. james berenson discusses the carfilzomib (kyprolis) toxicity profile
-
2:12
dr. fakhri on the use of carfilzomib in multiple myeloma
-
1:49
key challenges that remain in the diagnosis of al amyloidosis
-
0:47
dr. keith stewart discusses the efficacy of carfilzomib in the aspire trial
-
1:57
dr. paul on the role of carfilzomib in relapsed/refractory multiple myeloma
-
6:03
daratumumab with carfilzomib in frontline multiple myeloma
-
2:01
dr. joshua richter discusses multiple myeloma clinical trials
-
1:10
dr. chari discusses carfilzomib dosing in myeloma
-
1:11
dr. costello on determining proper dosing of carfilzomib in relapsed/refractory myeloma
-
1:10
dr. richter on novel oral anticoagulants
-
52:37
know your myeloma therapy: carfilzomib (kyprolis) with dr. harsh parmar
-
18:35
optimal usage of carfilzomib and pomalidomide in treating relapsed/refractory myeloma
-
0:11
copy of dr. fakhri on the use of carfilzomib in multiple myeloma
-
1:08
the forte clinical trial of carfilzomib in multiple myeloma